» Articles » PMID: 23814065

Niemann-pick Type C2 Deficiency in Human Fibroblasts Confers Robust and Selective Activation of Prostaglandin E2 Biosynthesis

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2013 Jul 2
PMID 23814065
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Activated fibroblasts, also known as myofibroblasts, are mediators of several major human pathologies including proliferative fibrotic disorders, invasive tumor growth, rheumatoid arthritis, and atherosclerosis. We previously identified Niemann-Pick type C2 (NPC2) protein as a negative regulator of fibroblast activation (Csepeggi, C., Jiang, M., Kojima, F., Crofford, L. J., and Frolov, A. (2011) J. Biol. Chem. 286, 2078-2087). Here we report that NPC2-deficiency leads to a dramatic up-regulation of the arachidonic acid (AA) metabolic pathway in human fibroblasts. The major enzymes in this pathway, cPLA2 type IVA, COX-2, and mPGES-1, were dramatically up-regulated at both the transcriptional and translational levels. The specific phenotypic changes resulted in a >10-fold increase in the production and secretion of a key modulator of inflammation and immunity, prostaglandin E2. More importantly, AA metabolome profiling by liquid chromatography/tandem mass-spectrometry revealed the very specific nature of prostaglandin E2 up-regulation as the other analyzed AA metabolites derived from the COX-2, cytochrome P450, 5/15-lipoxygenase, and non-enzymatic oxidative pathways were mostly down-regulated. Blocking activity of cPLA2 efficiently suppressed expression of inflammatory cytokines, IL-1β and IL-6, thereby identifying cPLA2 as an important regulator of the inflammatory program in NPC2-null cells. Altogether, these studies highlight NPC2 as a specific regulator of AA metabolism and inflammation that suggests potential for NPC2 protein or its related signaling in the treatment of inflammatory diseases characterized by the presence of activated fibroblasts.

Citing Articles

Niemann-Pick C2 Proteins: A New Function for an Old Family.

Zhu J, Guo M, Ban L, Song L, Liu Y, Pelosi P Front Physiol. 2018; 9:52.

PMID: 29472868 PMC: 5810286. DOI: 10.3389/fphys.2018.00052.

References
1.
Hinz B, Phan S, Thannickal V, Prunotto M, Desmouliere A, Varga J . Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol. 2012; 180(4):1340-55. PMC: 3640252. DOI: 10.1016/j.ajpath.2012.02.004. View

2.
Seymour M, Zaidi N, Hollenberg M, MacNaughton W . PAR1-dependent and independent increases in COX-2 and PGE2 in human colonic myofibroblasts stimulated by thrombin. Am J Physiol Cell Physiol. 2002; 284(5):C1185-92. DOI: 10.1152/ajpcell.00126.2002. View

3.
Okamura N, Kiuchi S, Tamba M, Kashima T, Hiramoto S, Baba T . A porcine homolog of the major secretory protein of human epididymis, HE1, specifically binds cholesterol. Biochim Biophys Acta. 1999; 1438(3):377-87. DOI: 10.1016/s1388-1981(99)00070-0. View

4.
Bhattacharyya S, Wei J, Varga J . Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities. Nat Rev Rheumatol. 2011; 8(1):42-54. PMC: 3954787. DOI: 10.1038/nrrheum.2011.149. View

5.
Csepeggi C, Jiang M, Frolov A . Somatic cell plasticity and Niemann-pick type C2 protein: adipocyte differentiation and function. J Biol Chem. 2010; 285(39):30347-54. PMC: 2943299. DOI: 10.1074/jbc.M110.135939. View